Cargando…
Implications of direct oral anticoagulation and antiplatelet therapy in intensive care
Autores principales: | Willcox, Abbey, Ho, Lisa, Jones, Daryl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692534/ https://www.ncbi.nlm.nih.gov/pubmed/32900323 http://dx.doi.org/10.1016/S1441-2772(23)00384-8 |
Ejemplares similares
-
New oral anticoagulants – will they be used with antiplatelet drugs in patients with atrial fibrillation after acute coronary syndrome?
por: Gorczyca-Michta, Iwona, et al.
Publicado: (2013) -
Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review
por: Matli, Kamal, et al.
Publicado: (2021) -
Outpatient cervical brachytherapy in the setting of ongoing antiplatelet therapy or oral anticoagulation
por: Valakh, Vladimir, et al.
Publicado: (2018) -
Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study
por: Matli, Kamal, et al.
Publicado: (2021) -
A surgeon's guide to anticoagulant and antiplatelet medications part one: warfarin and new direct oral anticoagulant medications
por: McBeth, Paul B, et al.
Publicado: (2016)